(Q37685759)

22 August 2017

1 reference

title

The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target? (English)

1 reference

22 August 2017

Ramamoorthy Rajkumar

1

1 reference

PubMed ID

20123937

22 August 2017

Radhakrishnan Mahesh

series ordinal

2

1 reference

PubMed ID

20123937

22 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Journal of Psychopharmacology

22 August 2017

1 reference

22 August 2017

24

1 reference

22 August 2017

455-469

1 reference

22 August 2017

4

1 reference

Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat

22 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

A Review of the Pharmacological and Clinical Profile of Mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Feedback stimulation of somatodendritic serotonin release: a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The 5-HT3 receptor--the relationship between structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

A review of central 5-HT receptors and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Deletion of the 5-HT3 receptor differentially affects behavior of males and females in the Porsolt forced swim and defensive withdrawal tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Functional characterization of a 5-HT3 receptor which modulates the release of 5-HT in the guinea-pig brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-HT3 receptors which modulate [3H]5-HT release in the guinea pig hypothalamus are not autoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The central 5-HT3 receptor in CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Role of the serotonergic system in the forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Evidence that imipramine activates 5-HT1C receptor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Laterality of dopamine function and neuroleptic action in the amygdala in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Identification of 5-HT3A and 5-HT3B receptor subunits in human hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Psychiatric comorbidity in patients with eating disorders1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Acute treatment with 5-HT3 receptor antagonist, tropisetron, reduces immobility in intact female rats exposed to the forced swim test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Ion permeation and conduction in a human recombinant 5-HT3 receptor subunit (h5-HT3A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Molecular cloning of alternatively spliced human 5-HT3 receptor cDNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Distribution and characterization of the [3H]granisetron-labelled 5-HT3 receptor in the human forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Comorbidity of fibromyalgia and psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Depression and eating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Nucleus accumbens muscarinic receptors in the control of behavioral depression: antidepressant-like effects of local M1 antagonist in the Porsolt swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Mechanism of block by fluoxetine of 5-hydroxytryptamine3 (5-HT3)-mediated currents in NCB-20 neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The psychopharmacology of 5-HT3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-HT3 serotonin hetero-receptors inhibit [3H]acethylcholine release in rat cortical synaptosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The 5-HT3B subunit is a major determinant of serotonin-receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Major depression and comorbid substance use disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

A prospective, open-label trial of ondansetron in adolescents with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Reductions in and relations between "craving" and drinking in a prospective, open-label trial of ondansetron in adolescents with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Opposite effects of presynaptic 5-HT3 receptor activation on spontaneous and action potential-evoked GABA release at hippocampal synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Immunolabeling of the rat central nervous system with antibodies partially selective of the short form of the 5-HT3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-HT3-like receptors in the rat medial prefrontal cortex: further pharmacological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Psychiatric disorders in patients with fibromyalgia. A multicenter investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Effects of antidepressants on the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Enhanced production of macrophage inhibitory protein-1alpha in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Treatment of psychosis in Parkinson's disease: safety considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Desperately seeking subunits: are native 5-HT3 receptors really homomeric complexes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Autoradiographic localization of the [3H]-(S)-zacopride labelled 5-HT3 receptor in porcine brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Distribution of serotonin 2A, 2C and 3 receptor mRNA in spinal cord and medulla oblongata

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Two kinds of tryptamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-d-aspartate in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Localization of 5-HT3 receptors in the rat brain using [3H]LY278584.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Localization of 5-HT2A, 5-HT3, 5-HT5A and 5-HT7 receptor-like immunoreactivity in the rat cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Presynaptic serotonin receptors in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Expression of recombinant homo-oligomeric 5-hydroxytryptamine3 receptors provides new insights into their maturation and structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Psychiatric comorbidity and depression in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5HT(3) antagonism abolishes the emotion potentiated startle effect in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Psychiatric comorbidity in treatment-seeking anorexics and bulimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Molecular, pharmacological and functional diversity of 5-HT receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-HT3A receptor subunits in the rat medial nucleus of the solitary tract: subcellular distribution and relation to the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The 5-HT3 receptor channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

3B but which 3B and that's just one of the questions: the heterogeneity of human 5-HT3 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Ondansetron reduces the craving of biologically predisposed alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Structural determinants of Ca2+ permeability and conduction in the human 5-hydroxytryptamine type 3A receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Olfactory bulbectomy as a model for agitated hyposerotonergic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Serotonin-3 receptors in the actions of alcohol, alcohol reinforcement, and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The 5-HT3 antagonist zacopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-HT3 receptor antagonists reverse helpless behaviour in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

A novel subpopulation of 5-HT type 3A receptor subunit immunoreactive interneurons in the rat basolateral amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Differential subcellular localization of the 5-HT3-As receptor subunit in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Evidence that the 5-HT3 receptors of the rat, mouse and guinea-pig superior cervical ganglion may be different

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Association between the 5' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Species variations in 5-HT3 recognition sites labeled by 3H-quipazine in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Autoradiography of [3H]quipazine in rodent brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Electrophysiology of 5-HT3 receptors in neuronal cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Recent advances in the electrophysiological characterization of 5-HT3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Release of cholecystokinin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Ondansetron and opiate craving. A novel pharmacological approach to addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

21 January 2018

The treatment of tics

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Serotonin 5-HT(3) receptors in rat CA1 hippocampal interneurons: functional and molecular characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Nervous system distribution of the serotonin 5-HT3 receptor mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

The 5-HT3 receptor as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Possible serotonin syndrome in association with 5-HT(3) antagonist agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-HT(3) receptors and neurotransmitter release in the CNS: a nerve ending story?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Organization of the mouse 5-HT3 receptor gene and functional expression of two splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Visual loss in Alzheimer's disease: out of sight, out of mind.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Antagonism of 5-HT3 receptors attenuates the effects of ethanol on extracellular dopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Structural features of the ligand-binding domain of the serotonin 5HT3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109348161

21 January 2018

Identifiers

DOI

10.1177/0269881109348161

1 reference

22 August 2017

1 reference

PubMed ID

20123937